Zhejiang Starry Pharmaceutical Co.,Ltd.
Status: Publicly traded
Direct answer
Zhejiang Starry Pharmaceutical Co.,Ltd. is publicly traded on SHH under the ticker 603520.SS.
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol,...
Can you invest in Zhejiang Starry Pharmaceutical Co.,Ltd.?
Yes. Zhejiang Starry Pharmaceutical Co.,Ltd. trades publicly on SHH as 603520.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zhejiang Starry Pharmaceutical Co.,Ltd.
Detailed equity research is provided by MarketSnap.